The marked levels of SOCS3 and STAT3 in the serum of children with AD suggest that these two proteins can be used as biomarkers to reflect the severity of the disease; therefore, their therapeutic modulation could be important in preventing the development of the disease [127]. Here, STAT3 is linked to Alzheimer disease.